BioSpace News Archive

Select Medical Holdings Corporation, announced that Select Medical Corporation has priced its private placement of $675 million aggregate principal amount of its 6.250% senior notes due 2026 as additional notes under the indenture pursuant to which it previously issued $550 million of 6.250% senior notes due 2026.

The American Urological Association announced the 2020 Gallagher Health Policy Scholar.

Prelude Corporation announced the official appointment of David J. Dabbs, MD, a world renowned expert in breast pathology, to its medical team to provide pathology leadership for both currently marketed tests and services and others in development.

Tauriga Sciences, Inc. announced its plans to develop a Cannabigerol Infused product to complement its existing Cannabidiol Isolate Infused product line: Tauri-Gum™ and Tauri-Gummies™.

Generex Biotechnology Corporation (OTCQB: GNBT) is pleased to announce that the company has finalized agreements to provide significant funding for ongoing operations, launching new businesses, and advancing the commercial development of new products from the NuGenerex family of companies

Hospitals achieved up to 98% decrease in MRSA superbug infection rates and $1.9 million in savings with programs using Nozin® Nasal Sanitizer® antiseptic on patients. Results reported at Association of Professionals in Infection Control (APIC) and Infectious Disease Society of America (IDSA IDWeek) annual conferences

The U.S. Food and Drug Administration today announced the global launch of CURE ID, an internet-based repository that will allow the clinical community to report their experiences treating difficult-to-treat infectious diseases with novel uses of existing FDA-approved drugs through a website, a smartphone or other mobile device

Movement Industries Corp. (OTC PINK: MVNT) announced today that the company has completed the acquisition of SGX Industrial LLC.

National Healthcareer Association recently announced the launch of PharmaSeer Math™, a new product that prepares current and future pharmacy technicians with the skills and confidence to master calculations used across all pharmacy settings.

Enzo Biochem, Inc. (NYSE:ENZ) will hold a conference call to discuss fiscal 2020 first quarter results on Tuesday, December 10, 2019, at 4:30 PM E.T.